Pharmacogenetics and Genomics · 2010 · 107 citations · 42 references
MedicineBiochemistryPharmacologyEnzymologyMetabolismStructural BiologyCatalytic MechanismsCytochrome P450 EnzymesCytochrome P450-mediated MetabolismDrug Metabolism GeneticsDrug-metabolizing EnzymesCatalytic ActivityCyp3a4 Genetic VariationCyp3a4 Variant EffectsCytochrome P450 3A4 MetabolismCytochrome P450 CatalysisMaximum Reaction VelocityOxidoreductase ActivityOxidoreductase Catalysis
OBJECTIVES: CYP3A4 receives electrons from P450 oxidoreductase (POR) to metabolize about 50% of clinically used drugs. There is substantial inter-individual variation in CYP3A4 catalytic activity that is not explained by CYP3A4 genetic variants. CYP3A4 is flexible and distensible, permitting it to accommodate substrates varying in shape and size. To elucidate the mechanisms of variability in CYP3A4 catalysis, we examined the effects of genetic variants of POR, and explored the possibility that substrate-induced conformational changes in CYP3A4 differentially affect the ability of POR variants to support catalysis. METHODS: We expressed human CYP3A4 and four POR variants (Q153R, A287P, R457H, A503 V) in bacteria, reconstituted them in vitro and measured the Michaelis constant and maximum velocity with testosterone, midazolam, quinidine and erythromycin as substrates. RESULTS: POR A287P and R457H had low activity with all substrates; Q153R had 76-94% of wild-type (WT) activity with midazolam and erythromycin, but 129-150% activity with testosterone and quinidine. The A503 V polymorphism reduced the CYP3A4 activity to 61-77% of WT with testosterone and midazolam, but had nearly WT activity with quinidine and erythromycin. CONCLUSION: POR variants affect CYP3A4 activities. The impact of a POR variant on catalysis by CYP3A4 is substrate-specific, probably because of substrate-induced conformational changes in CYP3A4.
42
The Carbon Monoxide-binding Pigment of Liver Microsomes
Tsuneo Omura, Ryo Sato · Journal of Biological Chemistry · 1964 · 11.8K citations · Full text
Crystal Structures of Human Cytochrome P450 3A4 Bound to Metyrapone and Progesterone
Pamela A. Williams, José Cosme, Dijana Matak‐Vinković et al. · Science · 2004 · 806 citations
Medicine, Biochemistry, Pharmacology +15
Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance
Shufeng Zhou · Clinical Pharmacokinetics · 2009 · 759 citations
Medicine, Genetics, Pharmacology +14